Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
8.69
-0.65 (-6.96%)
At close: Jul 24, 2026, 4:00 PM EDT
8.69
0.00 (0.00%)
After-hours: Jul 24, 2026, 4:10 PM EDT
Vir Biotechnology Market Cap
Vir Biotechnology has a market cap or net worth of $1.47 billion as of July 24, 2026. Its market cap has increased by 81.23% in one year.
Market Cap
1.47B
Enterprise Value
1.10B
1-Year Change
81.23%
Ranking
Category
Stock Price
$8.69
ChartMarket Cap Chart
Since October 11, 2019, Vir Biotechnology's market cap has decreased from $1.53B to $1.47B, a decrease of -4.44%. That is a compound annual growth rate of -0.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 1.47B | 74.70% |
| Dec 31, 2025 | 838.92M | -17.01% |
| Dec 31, 2024 | 1.01B | -25.30% |
| Dec 29, 2023 | 1.35B | -59.83% |
| Dec 30, 2022 | 3.37B | -38.52% |
| Dec 31, 2021 | 5.48B | 60.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zymeworks | 1.67B |
| Sarepta Therapeutics | 1.67B |
| MapLight Therapeutics | 1.60B |
| Innoviva | 1.58B |
| Recursion Pharmaceuticals | 1.58B |
| Maze Therapeutics | 1.58B |
| MoonLake Immunotherapeutics | 1.56B |
| AnaptysBio | 1.56B |